These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 29064399)

  • 1. Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases.
    Nguyen TTB; Jin YY; Chung HJ; Hong ST
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29064399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of diet and intestinal microbiota in the development of metabolic syndrome.
    Santos-Marcos JA; Perez-Jimenez F; Camargo A
    J Nutr Biochem; 2019 Aug; 70():1-27. PubMed ID: 31082615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next generation probiotics in disease amelioration.
    Chang CJ; Lin TL; Tsai YL; Wu TR; Lai WF; Lu CC; Lai HC
    J Food Drug Anal; 2019 Jul; 27(3):615-622. PubMed ID: 31324278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiometabolic risk management in type 2 diabetes and obesity.
    Taylor AM
    Curr Diab Rep; 2008 Oct; 8(5):345-52. PubMed ID: 18778582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics in human health and disease: from nutribiotics to pharmabiotics.
    Lee ES; Song EJ; Nam YD; Lee SY
    J Microbiol; 2018 Nov; 56(11):773-782. PubMed ID: 30353462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach.
    Santilli F; D'Ardes D; Guagnano MT; Davi G
    Curr Med Chem; 2017; 24(24):2602-2627. PubMed ID: 28699503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial normalization of components of metabolic syndrome does not influence prevalent echocardiographic abnormalities: the HyperGEN study.
    de Simone G; Arnett DK; Chinali M; De Marco M; Rao DC; Kraja AT; Hunt SC; Devereux RB
    Nutr Metab Cardiovasc Dis; 2013 Jan; 23(1):38-45. PubMed ID: 21570269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The advent of RNA-based therapeutics for metabolic syndrome and associated conditions: a comprehensive review of the literature.
    Huang HYR; Badar S; Said M; Shah S; Bharadwaj HR; Ramamoorthy K; Alrawashdeh MM; Haroon F; Basit J; Saeed S; Aji N; Tse G; Roy P; Bardhan M
    Mol Biol Rep; 2024 Apr; 51(1):493. PubMed ID: 38580818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the prevalence, progression, and management of metabolic syndrome in Saudi Arabia.
    Alshehri FF
    Saudi Med J; 2023 Oct; 44(10):973-986. PubMed ID: 37777274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut dysbiosis is linked to metabolic syndrome in obese Egyptian women: potential treatment by probiotics and high fiber diets regimen.
    Hassan NE; El-Masry SA; El Shebini SM; Ahmed NH; Mohamed T F; Mostafa MI; Afify MAS; Kamal AN; Badie MM; Hashish A; Alian K
    Sci Rep; 2024 Mar; 14(1):5464. PubMed ID: 38443406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of probiotics on each component of the metabolic syndrome and other cardiovascular risks.
    Miglioranza Scavuzzi B; Miglioranza LH; Henrique FC; Pitelli Paroschi T; Lozovoy MA; Simão AN; Dichi I
    Expert Opin Ther Targets; 2015; 19(8):1127-38. PubMed ID: 25872805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021.
    Fahed G; Aoun L; Bou Zerdan M; Allam S; Bou Zerdan M; Bouferraa Y; Assi HI
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Reversal Intervention for Metabolic Syndrome (TRIMS) study: rationale, design, and baseline data.
    Dunkley AJ; Davies MJ; Stone MA; Taub NA; Troughton J; Yates T; Khunti K
    Trials; 2011 May; 12():107. PubMed ID: 21542913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus.
    Katsiki N; Anagnostis P; Kotsa K; Goulis DG; Mikhailidis DP
    Curr Pharm Des; 2019; 25(18):2051-2059. PubMed ID: 31298151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome.
    Wang Y; Yu Q; Chen Y; Cao F
    Curr Pharm Des; 2013; 19(27):4799-805. PubMed ID: 23323622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Fasting Curb the Metabolic Syndrome Epidemic?
    Vrdoljak J; Kumric M; Vilovic M; Martinovic D; Rogosic V; Borovac JA; Ticinovic Kurir T; Bozic J
    Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional Approaches Targeting Gut Microbiota in Oxidative-Stress-Associated Metabolic Syndrome: Focus on Early Life Programming.
    Tain YL; Hsu CN
    Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effects of Gut Microbiota on Metabolic Syndrome: A Patent Review.
    Singhal S; Rani V
    Recent Adv Food Nutr Agric; 2022 Nov; 13(1):17-26. PubMed ID: 35307002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.
    Hoerger TJ; Ahmann AJ
    J Manag Care Pharm; 2008 Feb; 14(1 Suppl C):S2-14; quiz 15-6. PubMed ID: 18240890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipokines, metabolic syndrome and rheumatic diseases.
    Abella V; Scotece M; Conde J; López V; Lazzaro V; Pino J; Gómez-Reino JJ; Gualillo O
    J Immunol Res; 2014; 2014():343746. PubMed ID: 24741591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.